HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas

Aberrant expression of human leukocyte antigens (HLA) class I has prognostic importance in various cancers. Here, we evaluated the prognostic value of classical (A/B/C) and nonclassical (G/E) HLA expression in 169 high grade epithelial ovarian cancer samples and linked that to clinicopathological ch...

Full description

Saved in:
Bibliographic Details
Main Authors: M. J. Rutten, F. Dijk, C. D. Savci-Heijink, M. R. Buist, G. G. Kenter, M. J. van de Vijver, E. S. Jordanova
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2014/274584
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565050680803328
author M. J. Rutten
F. Dijk
C. D. Savci-Heijink
M. R. Buist
G. G. Kenter
M. J. van de Vijver
E. S. Jordanova
author_facet M. J. Rutten
F. Dijk
C. D. Savci-Heijink
M. R. Buist
G. G. Kenter
M. J. van de Vijver
E. S. Jordanova
author_sort M. J. Rutten
collection DOAJ
description Aberrant expression of human leukocyte antigens (HLA) class I has prognostic importance in various cancers. Here, we evaluated the prognostic value of classical (A/B/C) and nonclassical (G/E) HLA expression in 169 high grade epithelial ovarian cancer samples and linked that to clinicopathological characteristics and survival. Expression of HLA-A, -B/C, or -E was not correlated with survival. Survival was prolonged when tumours expressed HLA-G (P=0.008) and HLA-G was an independent predictor for better survival (P=0.011). In addition, HLA-G expression was associated with longer progression-free survival (P=0.036) and response to chemotherapy (P=0.014). Accordingly, high expression of HLA-G mRNA was associated with prolonged disease-free survival (P=0.037) in 65 corresponding samples. Elevated serum-soluble HLA-G levels as measured by enzyme-linked immunosorbent assay in 50 matched patients were not correlated to HLA-G protein expression or gene expression nor with survival. During treatment, sHLA-G levels declined (P=0.038). In conclusion, expression of HLA-G is an independent prognostic factor for improved survival in high grade epithelial ovarian cancer and a predictor for platinum sensitivity.
format Article
id doaj-art-b14771ed493340ef9d2893c277f1a480
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-b14771ed493340ef9d2893c277f1a4802025-02-03T01:09:40ZengWileyJournal of Immunology Research2314-88612314-71562014-01-01201410.1155/2014/274584274584HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian CarcinomasM. J. Rutten0F. Dijk1C. D. Savci-Heijink2M. R. Buist3G. G. Kenter4M. J. van de Vijver5E. S. Jordanova6Academic Medical Center, Center of Gynaecologic Oncology, Amsterdam, The NetherlandsDepartment of Pathology, Academic Medical Center, Amsterdam, The NetherlandsDepartment of Pathology, Academic Medical Center, Amsterdam, The NetherlandsAcademic Medical Center, Center of Gynaecologic Oncology, Amsterdam, The NetherlandsAcademic Medical Center, Center of Gynaecologic Oncology, Amsterdam, The NetherlandsDepartment of Pathology, Academic Medical Center, Amsterdam, The NetherlandsFree University Medical Center, Center of Gynaecologic Oncology, Amsterdam, The NetherlandsAberrant expression of human leukocyte antigens (HLA) class I has prognostic importance in various cancers. Here, we evaluated the prognostic value of classical (A/B/C) and nonclassical (G/E) HLA expression in 169 high grade epithelial ovarian cancer samples and linked that to clinicopathological characteristics and survival. Expression of HLA-A, -B/C, or -E was not correlated with survival. Survival was prolonged when tumours expressed HLA-G (P=0.008) and HLA-G was an independent predictor for better survival (P=0.011). In addition, HLA-G expression was associated with longer progression-free survival (P=0.036) and response to chemotherapy (P=0.014). Accordingly, high expression of HLA-G mRNA was associated with prolonged disease-free survival (P=0.037) in 65 corresponding samples. Elevated serum-soluble HLA-G levels as measured by enzyme-linked immunosorbent assay in 50 matched patients were not correlated to HLA-G protein expression or gene expression nor with survival. During treatment, sHLA-G levels declined (P=0.038). In conclusion, expression of HLA-G is an independent prognostic factor for improved survival in high grade epithelial ovarian cancer and a predictor for platinum sensitivity.http://dx.doi.org/10.1155/2014/274584
spellingShingle M. J. Rutten
F. Dijk
C. D. Savci-Heijink
M. R. Buist
G. G. Kenter
M. J. van de Vijver
E. S. Jordanova
HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
Journal of Immunology Research
title HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
title_full HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
title_fullStr HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
title_full_unstemmed HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
title_short HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
title_sort hla g expression is an independent predictor for improved survival in high grade ovarian carcinomas
url http://dx.doi.org/10.1155/2014/274584
work_keys_str_mv AT mjrutten hlagexpressionisanindependentpredictorforimprovedsurvivalinhighgradeovariancarcinomas
AT fdijk hlagexpressionisanindependentpredictorforimprovedsurvivalinhighgradeovariancarcinomas
AT cdsavciheijink hlagexpressionisanindependentpredictorforimprovedsurvivalinhighgradeovariancarcinomas
AT mrbuist hlagexpressionisanindependentpredictorforimprovedsurvivalinhighgradeovariancarcinomas
AT ggkenter hlagexpressionisanindependentpredictorforimprovedsurvivalinhighgradeovariancarcinomas
AT mjvandevijver hlagexpressionisanindependentpredictorforimprovedsurvivalinhighgradeovariancarcinomas
AT esjordanova hlagexpressionisanindependentpredictorforimprovedsurvivalinhighgradeovariancarcinomas